MLS expands biotech plant
Meridian Life Science (MLS) has completed the expansion of its cGMP biotech facility, which will enable the contract production of vaccines and viral based products for Phase I trials.
Archives for July 28, 2009
Mylan & FDA appear to disagree on QC inquiry
Mylan and the FDA appear to be in disagreement about whether investigations into quality controls at a US facility are ongoing, with both releasing seemingly contradictory statements.
Covance doubles metabolite testing capacity
US CRO Covance has expanded its preclinical development offering, doubling metabolite identification capacity at its facility in Madison, Wisconsin.
Caraco posts loss following cGMP issues
The financial impact of Caraco’s cGMP compliance issues have been revealed in its Q1 results, which saw a $14m (€9.9m) operating income in 2008 turn into a $14m loss this year.
JLL bid “irrelevant”, says Patheon after win in Canadian Courts
In the latest twist in an increasing bitter takeover battle, the Ontario Superior Court of Justice has rejected JLL’s bid to oust directors elected to the board of Canadian CMO Patheon in April.